Teleflex Incorporated (NYSE:TFX - Get Free Report) declared a quarterly dividend on Thursday, July 31st, RTT News reports. Investors of record on Friday, August 15th will be paid a dividend of 0.34 per share by the medical technology company on Monday, September 15th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, August 15th.
Teleflex has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.
Teleflex Trading Down 3.0%
Shares of TFX traded down $3.63 on Friday, hitting $115.87. 642,835 shares of the stock traded hands, compared to its average volume of 535,501. The company has a quick ratio of 1.32, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $5.12 billion, a P/E ratio of 27.26, a P/E/G ratio of 1.87 and a beta of 1.08. The stock's 50 day moving average is $118.73 and its two-hundred day moving average is $137.16. Teleflex has a 1 year low of $108.90 and a 1 year high of $249.90.
Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.42 earnings per share. As a group, sell-side analysts predict that Teleflex will post 13.98 earnings per share for the current year.
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.